Taiwan FDA registration 946c17555f01c5bf483d52a1da918186

Imno Consest extracts nuclear antigen autologous antibody enzyme immunoassay reagent

TW: 伊姆諾康塞斯特可萃取核抗原自體抗體酵素免疫測試試劑

Taiwan·Risk Class 2·IMMUNO CONCEPTS NA LTD·Registered Mar 22, 2006 – Mar 22, 2016Cancelled

Registration details

Analysis ID: 946c17555f01c5bf483d52a1da918186
Customs Code: DHA00601619702

Company information

Manufacturer: IMMUNO CONCEPTS NA LTD
Manufacturer Country: United States
Authorized Representative: GRANT TECHNOLOGY CO., LTD.

Product details

Intended Use: 偵測可萃取核抗原(extractable nuclear antigens, ENA)人體血漿中對抗Sm(Smith)、RNP、SS-A(ro)、SS-B(La)、Scl-70與Jo-1的抗體.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.5100 抗核抗體免疫試驗系統
Import Information: import

Dates and status

Registration Date: Mar 22, 2006
Expiry Date: Mar 22, 2016
Cancellation Date: May 10, 2018

Cancellation information

Status: Logged out
Reason: 許可證已逾有效期

About this record

Access comprehensive regulatory information for Imno Consest extracts nuclear antigen autologous antibody enzyme immunoassay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 946c17555f01c5bf483d52a1da918186 and manufactured by IMMUNO CONCEPTS NA LTD. The authorized representative in Taiwan is GRANT TECHNOLOGY CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.